Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03925129 · ClinicalTrials.gov registry record · NA
Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Management With Medication Abortion Through 70 Days' Gestation
A NA study, sponsored by Planned Parenthood of Greater New York.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03925129 is a NA study that has completed, run by Planned Parenthood of Greater New York. The registered enrollment target is 40 participants.
The verdict
NCT03925129, a NA study, has completed, sponsored by Planned Parenthood of Greater New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This is a double-blinded, randomized, placebo-controlled trial evaluating the use of High-frequency Transcutaneous Electrical Nerve Stimulation (HfTENS) compared to sham TENS for pain control during medication abortion with mifepristone and misoprostol through 70 days' gestation.
Interventions
- DEVICE high frequency TENS treatment
- DEVICE Sham TENS treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2019-06-11 |
| Est. Completion | 2020-03-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03925129
The ClinicalTrials.gov registry entry for NCT03925129 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Planned Parenthood of Greater New York, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which high frequency TENS treatment is the first listed.
NCT03925129 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03925129 about?
NCT03925129 is a clinical study titled "Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Management With Medication Abortion Through 70 Days' Gestation". This is a double-blinded, randomized, placebo-controlled trial evaluating the use of High-frequency Transcutaneous Electrical Nerve Stimulation (HfTENS) compared to sham TENS for pain control during medication abortion with mifepristone and misoprostol through 70 days' gestation.
What is the current status of trial NCT03925129?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2019-06-11. Estimated completion is 2020-03-13.
What interventions are being tested in trial NCT03925129?
The interventions under investigation include: high frequency TENS treatment (DEVICE), Sham TENS treatment (DEVICE).
Who is sponsoring clinical trial NCT03925129?
This trial is sponsored by Planned Parenthood of Greater New York, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.